Taisho Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taisho Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for dialysis patients battling dangerous mineral buildup
Disease control CompletedThis study tested a new drug called TS-172 to see if it could safely lower high phosphorus levels in people on kidney dialysis. High phosphorus is a common and serious problem for dialysis patients. Researchers compared the drug to a placebo (a dummy pill) in 101 patients to see …
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
Early drug timing test shows minimal public impact
Knowledge-focused CompletedThis small, completed study aimed to understand how the timing of taking an experimental drug, TS-172, affects its action in the body. It involved 16 healthy Japanese men to measure changes in minerals in their urine. The goal was to gather basic information, not to treat any dis…
Phase: PHASE1 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC